회원로그인

мȸ ǥ ʷ

ǥ : ȣ - 470529   12 
Contribution of Genetic Characteristics of Vascular Adrenergic Receptor to Variant Angina
서울대학교병원 심혈관센터, 임상의학연구소 심혈관연구실/ 서울대학교 의과대학 내과학교실
조상호, 서재빈, 장서영, 박진식, 조영석, 최진호, 구본권, 김용진, 오세일, 채인호, 김효수, 손대원, 오병희, 이명묵, 박영배, 최윤식
Background: The Α2 or Β2 adrenergic receptor in vasculature mediate vasoconstriction or dilation respectively in response to adrenergic agents, and Β1 adrenergic receptor in heart mediates chronotrophic and inotrophic changes. We investigate the relationship of vasospastic angina and four kinds of adrenergic receptor polymorphisms (Α2 Del 322-325, Β2 Gly16, Β2 Glu27 and Β1 Arg389). Methods: Vasospastic angina (N=162) was confirmed by focal coronary spasm in CAG with chest pain or ST elevation on ECG after ergonovine intravenous infusion. Normal control group comprised 129 subjects who showed normal coronary angiogram. After a diagnostic coronary angiography was performed, four kinds of genotypes were identified separately using different PCR and RFLP methods from the DNA extracted from the peripheral monocytes. Results: The allele frequencies of four kinds of adrenergic receptor polymorphisms (Α2 Del 322-325, Β2 Gly16, Β2 Glu27 and Β1 Arg389) in normal control were 0.23, 0.69, 0.53 and 0.17 respectively, and these are different from those of Caucasians (0.04, 0.61, 0.43, 0.73). The differences were prominent in Α2 Del 322-325 and Β1 Arg389. The frequencies of Α2 Del 322-325 polymorphism were significantly higher in variant angina group than in control, 16.4% and 0.8% respectively (p<0.0001). The Β2 polymorphism of codon 27(Glu27) is much less frequent in variant angina group than in control(29.3% : 49.3%, p<0.0001). However, there was no difference in the prevalence of Β2 polymorphism of codon 16(Gly16) or Β1 polymorphism between the two groups. Conclusion: The Del (322-325) mutant of Α2 receptor is a new genetic risk factors for variant angina, and Glu27 allele of the Β2 adrenergic receptor is a negative risk factor for variant angina. This is the first report in the world to demonstrate the contribution of genetic characteristics of the vascular adrenergic system to coronary vasospasm.


[ư]